Crypto Market Cap, BTC/USD, ETH/USD, USDT/USD, XRP/USD, Bitcoin
Apple, Advanced Micro Devices Inc, Amazon Com Inc, TESLA INC, NETFLIX INC, Facebook Inc
S&P 500, Nasdaq 100, Dow 30, Russell 2000, U.S. Dollar Index, Bitcoin Index
US 10Y, Euro Bund, Germany 10Y, Japan 10Y Yield, UK 10Y, India 10Y
Contextual immersion trading strategy idea. Cidara Therapeutics is a biotechnology company, focuses on the discovery, development, and commercialization of novel anti-infectives for the treatment of diseases The demand for shares of the company looks higher than the supply. Due to the spread of COVID-19, the demand for the company`s services rose. This and...
• CDTX • Entry: 3.61 • Stop loss: 3.20 (-11.35%) • Profit target 1: 4.36 (20.77%)
Stock has formed a very strong base and in a very strong uptrend, looks very healthy for more possible gains
CDTX: Cidara Therapeutics, Inc. 2018-09-25 08:00:00 FDA Grants QIDP and Fast Track Designations to Cidara Therapeutics’ Rezafungin Prophylaxis Development Program
CDTX - Looking for a break above 4.73. Possible fallen angel with possible longer term rally potential to 7.83.
Phase 2 trial results due anytime now. Watching for levels where CEO and CMO have been buying to potentially get in.
CDTX can reach to there 200 MA , good news on the way .